Clinical Trial Update: Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination chemotherapy regimen in patients with acute myeloid leukemia or myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Drugs mentioned

• Combination chemotherapy regimen (unspecified)

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia | Phase 2 | Status: COMPLETED